Zentalis Pharmaceuticals Inc. (ZNTL): Price and Financial Metrics

Zentalis Pharmaceuticals Inc. (ZNTL): $3.13

0.14 (+4.68%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

C

Add ZNTL to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#78 of 332

in industry

ZNTL Price/Volume Stats

Current price $3.13 52-week high $18.07
Prev. close $2.99 52-week low $2.66
Day low $2.90 Volume 1,244,400
Day high $3.20 Avg. volume 1,330,391
50-day MA $3.42 Dividend yield N/A
200-day MA $7.77 Market Cap 223.06M

ZNTL Stock Price Chart Interactive Chart >


Zentalis Pharmaceuticals Inc. (ZNTL) Company Bio


Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations. Its lead product candidate, ZN-c5, is an oral selective estrogen receptor degrader (SERD) for the treatment of estrogen receptor positive, human epidermal growth factor receptor 2-negative (ER+/HER2-) advanced or metastatic breast cancer. The company was founded by Kevin D. Bunker on December 23, 2014 and is headquartered in New York, NY.


ZNTL Latest News Stream


Event/Time News Detail
Loading, please wait...

ZNTL Latest Social Stream


Loading social stream, please wait...

View Full ZNTL Social Stream

ZNTL Price Returns

1-mo 0.32%
3-mo -1.88%
6-mo -72.23%
1-year -69.96%
3-year -95.81%
5-year N/A
YTD -79.34%
2023 -24.78%
2022 -76.04%
2021 61.84%
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!